Accuracy and precision in HER2/neu testing in breast cancer: are we there yet?
- 23 February 2004
- journal article
- editorial
- Published by Elsevier in Human Pathology
- Vol. 35 (2) , 143-146
- https://doi.org/10.1016/j.humpath.2004.01.002
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Current Perspectives on HER2 Testing: A Review of National Testing GuidelinesLaboratory Investigation, 2003
- HER-2/neu in Breast Cancer: Interobserver Variability and Performance of Immunohistochemistry with 4 Antibodies Compared with Fluorescent In Situ HybridizationLaboratory Investigation, 2001
- Defining a Test for HER-2/neu Evaluation in Breast Cancer in the Diagnostic SettingLaboratory Investigation, 2001
- Suggestions for HER-2/neu testing in breast carcinoma, based on a comparison of immunohistochemistry and Fluorescence in situ hybridisationPathology, 2001
- Strong Correlation between Results of Fluorescent In Situ Hybridization and Immunohistochemistry for the Assessment of the ERBB2 (HER-2/neu) Gene Status in Breast CarcinomaLaboratory Investigation, 2000
- HER-2/neu Testing in Breast Carcinoma: A Combined Immunohistochemical and Fluorescence In Situ Hybridization ApproachLaboratory Investigation, 2000
- HER-2/neu Gene Amplification Compared With HER-2/neu Protein Overexpression and Interobserver Reproducibility in Invasive Breast CarcinomaAmerican Journal of Clinical Pathology, 2000
- Immunohistochemical Determination of HER-2/neu Expression in Invasive Breast CarcinomaAmerican Journal of Clinical Pathology, 2000
- HER-2/neu Protein Expression in Breast Cancer Evaluated by ImmunohistochemistryAmerican Journal of Clinical Pathology, 2000
- HER-2/neu Assessment in Breast Cancer by Immunohistochemistry and Fluorescence In Situ Hybridization: Comparison of Results and Correlation With SurvivalMolecular Diagnosis, 2000